Thanks for posting this interesting article. I wonder if SPL will get any of the action? Any biopharmas that help prevent such widespread and costly diseases as macular degeneration (and to a lesser extent, pigmentosa) would have good commercial prospects.
Have a safe and happy Christmas everyone.
dendrimers used to delay macular degeneration, page-2
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.002(2.04%) |
Mkt cap ! $41.81M | |||
| Open | High | Low | Value | Volume |
| 9.8¢ | 10.0¢ | 9.7¢ | $37.90K | 384.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 68758 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 213426 | 6 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |